Search alternatives:
studies decrease » sizes decrease (Expand Search), step decrease (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
studies decrease » sizes decrease (Expand Search), step decrease (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
-
1
Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx
Published 2025“…Introduction<p>The emergence of artificial intelligence (AI) large language models (LLMs), which can produce text that closely resembles human-written content, presents both opportunities and risks. …”
-
2
-
3
-
4
-
5
-
6
-
7
Results of the molecular docking.
Published 2025“…All these compounds were then docked to the mutated Cystic Fibrosis Transmembrane Regulator (CFTR) protein. …”
-
8
Results of Molecular Docking.
Published 2025“…All these compounds were then docked to the mutated Cystic Fibrosis Transmembrane Regulator (CFTR) protein. …”
-
9
-
10
Raw data of Fig 2-Fig 13 in this study.
Published 2025“…TsSPc is involved in larval invasion of gut epithelium, but the mechanism is not completely elucidated. The purpose of this study was to investigate the mechanism of TsSPc action in larval invasion of gut mucosa.…”
-
11
-
12
-
13
-
14
Data Sheet 1_In silico molecular studies of Phosphinogold(I) thiocarbohydrate complexes: insights into multi-target anticancer mechanisms.docx
Published 2025“…Complex 13 demonstrated high in vitro activity against prostate, colon, and breast cancer cell lines (IC50 = 0.03, 0.25, and 0.07 μM respectively), collaborating with a significant interaction with Human Epidermal Growth Factor Receptor 2 (HER2) (–71.15 kcal/mol binding affinity) in silico. While acetylation decreased binding affinity; it enhanced cellular activity as reported in in vitro studies indicative of the need to balance lipophilicity and binding strength in future ligand design.…”
-
15
-
16
-
17
-
18
-
19
-
20